GenetiSure Dx Postnatal Assay Can Help Move Inquiries from Cause to Care Faster SANTA CLARA, Calif., March 2, 2017 Agilent Technologies Inc. (NYSE: A) has introduced its first comparative genomic hybridization (CGH) assay for diagnostic use: the GenetiSure Dx Postnatal Assay. This assay will enable clinical geneticists to detect genetic anomalies earlier and more accurately... Read more
CAMBRIDGE, UK – 27 February, 2017 – Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financing round. Existing investors, Cambridge Innovation Capital plc (CIC) and Amadeus Capital Partners (Amadeus) participated alongside new investor, Parkwalk Advisors (Parkwalk). Congenica will use the Series B... Read more
14 Feb, 2017, 09:00 ET SEOUL, South Korea, Feb. 14, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies today announced that it has developed a new software technology that can normalize test results of real-time PCR molecular diagnosis systems. This new innovative technology calibrates test results by correcting signal variations... Read more
BERWYN, Pa., Feb. 7, 2017 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Rauland-Borg Corporation, a leading global provider of mission critical communication solutions for hospitals, healthcare systems and educational facilities. Rauland-Borg was acquired for $340 million, plus a potential contingent payment of $30 million tied to the achievement... Read more
2017 2017/01/30 Announcement on submission of the Clinical Trial Plan Notification for phase II clinical trial of Oncolytic virus HF10 in Japan Kusatsu/Shiga, Japan — January 30, 2017 — Takara Bio Inc. (Takara Bio), today announced that the Clinical Trial Notification was submitted to PMDA (Pharmaceuticals and Medical Devices Agency; Japanese regulatory agency) to conduct... Read more
2017 2017/01/24 Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of NY-ESO-1・siTCR gene therapy in Japan Kusatsu/Shiga, Japan — January 24, 2017 — Takara Bio Inc. (Takara Bio), today announced that it has submitted the Clinical Trial Notification for regenerative medicines to PMDA (Pharmaceuticals and Medical Devices Agency), Japanese... Read more
Enzo Life Sciences is proud to introduce the SCREEN-WELL® Cancer Library, a collection of 275 ready-to-use compounds for use in cancer inhibitor screening and assay development. The SCREEN-WELL® Cancer Library is comprised of compounds that are dissolved at 10 mM in DMSO and aliquoted at 100 µL per well in deep 96-well plates. It contains... Read more
Uppsala, Sweden, 19 January 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Gerrit van den Dool to its Board of Directors, as a Non-Executive Director. With more than 25 years’ experience in the life science industry and with his... Read more
WARREN, N.J., Jan. 17, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens today announced the appointment of Mary Duseau as President and CEO. Ms. Duseau succeeds Paul Thomas, the Company’s President and CEO since 2009, who will assume the... Read more
Congenica Expands in North America with Strategic Appointment Shikha O’Brien, Chief Business Officer Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer 16th January 2017, Cambridge UK Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha... Read more